Trial · NCT02014519
Results by group82
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 82
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Seropositive Subjects in Terms of Anti-pertussis Toxin (Anti-PT) Concentrations | Study Group | 295 | Participants | ||
| Number of Subjects With Anti-PT IgG Levels Strongly Indicative of Current/Recent Infection | Study Group | 2 | Participants | ||
| Number of Subjects With Anti-PT IgG Levels Indicative of Current/Recent Infection | Study Group | 22 | Participants | ||
| Number of Seronegative Subjects in Terms of Anti-PT Concentrations | Study Group | 1704 | Participants | ||
| Number of Seropositive Subjects in Terms of Anti-PT Concentrations (by Age) | 18-29 Years Group | 67 | Participants | ||
| Number of Seropositive Subjects in Terms of Anti-PT Concentrations (by Age) | 30-44 Years Group | 67 | Participants | ||
| Number of Seropositive Subjects in Terms of Anti-PT Concentrations (by Age) | 45-59 Years Group | 56 | Participants | ||
| Number of Seropositive Subjects in Terms of Anti-PT Concentrations (by Age) | ≥ 60 Years Group | 105 | Participants | ||
| Number of Subjects With Anti-PT IgG Levels Strongly Indicative of Current/Recent Infection (by Age) | 18-29 Years Group | 0 | Participants | ||
| Number of Subjects With Anti-PT IgG Levels Strongly Indicative of Current/Recent Infection (by Age) | 30-44 Years Group | 1 | Participants | ||
| Number of Subjects With Anti-PT IgG Levels Strongly Indicative of Current/Recent Infection (by Age) | 45-59 Years Group | 1 | Participants | ||
| Number of Subjects With Anti-PT IgG Levels Strongly Indicative of Current/Recent Infection (by Age) | ≥ 60 Years Group | 0 | Participants | ||
| Number of Subjects With Anti-PT IgG Levels Indicative of Current/Recent Infection (by Age) | 18-29 Years Group | 2 | Participants | ||
| Number of Subjects With Anti-PT IgG Levels Indicative of Current/Recent Infection (by Age) | 30-44 Years Group | 5 | Participants | ||
| Number of Subjects With Anti-PT IgG Levels Indicative of Current/Recent Infection (by Age) | 45-59 Years Group | 4 | Participants | ||
| Number of Subjects With Anti-PT IgG Levels Indicative of Current/Recent Infection (by Age) | ≥ 60 Years Group | 11 | Participants | ||
| Number of Seronegative Subjects in Terms of Anti-PT Concentrations (by Age) | 18-29 Years Group | 341 | Participants | ||
| Number of Seronegative Subjects in Terms of Anti-PT Concentrations (by Age) | 30-44 Years Group | 474 | Participants | ||
| Number of Seronegative Subjects in Terms of Anti-PT Concentrations (by Age) | 45-59 Years Group | 453 | Participants | ||
| Number of Seronegative Subjects in Terms of Anti-PT Concentrations (by Age) | ≥ 60 Years Group | 436 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02014519/results